Document Detail


The effect of a high-fat meal on the oral bioavailability of the immunosuppressant sirolimus (rapamycin).
MedLine Citation:
PMID:  10579146     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The bioavailability of an oral nonaqueous solution of sirolimus was compared under fasting conditions and after a high-fat meal in a randomized, two-way crossover pharmacokinetic study. Healthy volunteers were administered a 15 mg single dose of sirolimus on two occasions, once while fasting and once after consumption of a high-fat breakfast. Whole blood concentrations of sirolimus were assayed by using a validated method with high-performance liquid chromatography/tandem mass spectrometric detection. Sirolimus was absorbed more slowly when administered after a high-fat meal than when administered after fasting, as shown by statistically significant reductions in peak concentration (Cmax) and the ratio of Cmax to the area under the curve (AUC), and lengthening of the time to peak concentration. The oral availability of sirolimus was increased to a modest extent (35%) and in a uniform manner when administered with a high-fat meal; the geometric mean ratio of the fed/fasting AUC values was 1.35, with a 90% confidence interval of 1.26 to 1.46. Food had no effect on the terminal half-life of sirolimus (mean values of 67 to 68 hours). The 35% increase in AUC obtained after a high-fat meal appears small relative to the intersubject and intrasubject variabilities observed in clinical trials. However, to minimize unnecessary fluctuations in trough whole blood sirolimus concentrations, it is advisable that sirolimus be administered consistently in individual patients, either with or without meals.
Authors:
J J Zimmerman; G M Ferron; H K Lim; V Parker
Related Documents :
17515696 - The pharmacokinetics of cinacalcet are unaffected following consumption of high- and lo...
21255596 - Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitaz...
3320156 - Polyunsaturated fatty acids augment insulin secretion.
10350016 - Meal composition effects on the oral bioavailability of indinavir in hiv-infected patie...
10698556 - Determination of a novel bile acid sequestrant in rodent diet by near-infrared spectros...
17235146 - Effect of photoperiod in the third trimester of gestation on milk production and circul...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of clinical pharmacology     Volume:  39     ISSN:  0091-2700     ISO Abbreviation:  J Clin Pharmacol     Publication Date:  1999 Nov 
Date Detail:
Created Date:  1999-12-16     Completed Date:  1999-12-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0366372     Medline TA:  J Clin Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1155-61     Citation Subset:  IM    
Affiliation:
Clinical Pharmacokinetics Department, Wyeth-Ayerst Research, Philadelphia, Pennsylvania 19101-2528, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Biological Availability
Cross-Over Studies
Dietary Fats / pharmacology*
Fasting
Female
Food-Drug Interactions
Gas Chromatography-Mass Spectrometry
Humans
Immunosuppressive Agents / blood,  pharmacokinetics*
Male
Patient Dropouts
Sirolimus / blood,  pharmacokinetics*
Time Factors
Chemical
Reg. No./Substance:
0/Dietary Fats; 0/Immunosuppressive Agents; 53123-88-9/Sirolimus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacokinetics of calcium absorption from two commercial calcium supplements.
Next Document:  Single-dose oral pharmacokinetics of three formulations of thalidomide in healthy male volunteers.